SG

Shailesh Gautamchand Mugdiya

Active Director Director DIN 10800828
DIN 10800828 First appointment Oct 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Shailesh Gautamchand Mugdiya

Data last updated:

Shailesh Gautamchand Mugdiya is a Director at Medonyx Life Science Private Limited (since 2024). The company operates in Paper.

DIN 10800828
Primary Designation Director
Industry Paper
First Appointment 07 Oct 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medonyx Life Science Private Limited U21000MH2024PTC433253
Director07 Oct 20242024Active

Board colleagues of Shailesh Gautamchand Mugdiya

NameDINCompanyDesignation
Rupali Umesh Mugdiya10800827Medonyx Life Science Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medonyx Life Science Private Limited
Premium access

Shareholding and investment profile for Shailesh Gautamchand Mugdiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shailesh Gautamchand Mugdiya

Shailesh Gautamchand Mugdiya currently holds 1 directorship: Medonyx Life Science Private Limited (Director, since 07 Oct 2024).

Shailesh Gautamchand Mugdiya was first appointed on 07 Oct 2024 as Director at Medonyx Life Science Private Limited.

The current boards of Shailesh Gautamchand Mugdiya's companies include Rupali Umesh Mugdiya (Medonyx Life Science Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available